Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects

Neurobiology of Learning and Memory

Volumn 88, Issue 3, 2007, Pages 312-320

  LeBlanc Duchin, Denise ^a   Taukulis, Harald K ^a  

^a UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

Chronic treatment; Object recognition test; Open field test; Oral methylphenidate; Periadolescent rats; Recognition memory

Indexed keywords

METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; MALE; MEMORY; MEMORY DISORDER; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PERFORMANCE; RAT; RECOGNITION; TASK PERFORMANCE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; FOLLOW-UP STUDIES; FORM PERCEPTION; MALE; METHYLPHENIDATE; RATS; RECOGNITION (PSYCHOLOGY); RETENTION (PSYCHOLOGY); TIME FACTORS;

EID: 34548289949     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2007.04.010     Document Type: Article

References (49)

1. Ainge J.A., Heron-Maxwell C., Theofilas P., Wright P., de Hoz L., and Wood E.R. The role of the hippocampus in object recognition in rats: Examination of the influence of task parameters and lesion size. Behavioural Brain Research 167 (2006) 183-195
2. Andersen S.L. Trajectories of brain development: Point of vulnerability or window of opportunity?. Neuroscience and Biobehavioral Reviews 27 (2003) 3-18
3. Aoyama T., Kotaki H., and Iga T. Dose-dependent kinetics of methylphenidate enantiomers after oral administration of racemic methylphenidate to rats. Journal of Pharmacobio-Dynamics 13 (1990) 647-652
4. Arnsten A.F.T. Catecholamine modulation of prefrontal cortical cognitive function. Trends in Cognitive Sciences 2 (1998) 436-447
5. Arnsten A.F.T., and Li B.-M. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biological Psychiatry 57 (2005) 1377-1384
6. Bartolini L., Casamenti F., and Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacology, Biochemistry and Behavior 53 (1996) 277-283
7. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacology, Biochemistry and Behavior 64 (1999) 803-812
8. Bisagno V., Ferguson D., and Luine V.N. Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Research 940 (2002) 95-101
9. Bisagno V., Ferguson D., and Luine V.N. Chronic d-amphetamine induces sexually dimorphic effects on locomotion, recognition memory, and brain monoamines. Pharmacology, Biochemistry and Behavior 74 (2003) 859-867
10. Bolaños C.A., Barrot M., Berton O., Wallace-Black D., and Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biological Psychiatry 54 (2003) 1317-1329
11. Brake W.G., Zhang T.Y., Diorio J., Meaney M.J., and Gratton A. Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. European Journal of Neuroscience 19 (2004) 1863-1874
12. Brandon C.L., Marinelli M., Baker L.K., and White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25 (2001) 651-661
13. Broadhurst P.L. Determinants of emotionality in the rat: I. Situational factors. British Journal of Psychology 48 (1957) 1-12
14. Canadian Pharmacists Association (2005). Compendium of pharmaceuticals and specialties: The Canadian drug reference for health professionals. Toronto, Ontario.
15. Carlezon Jr. W.A., and Konradi C. Understanding the neurobiological consequences of early exposure to psychotropic drugs: Linking behavior with molecules. Neuropharmacology 47 (2004) 47-60
16. Carlezon Jr. W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biological Psychiatry 54 (2003) 1330-1337
17. Chuhan Y.S., and Taukulis H.K. Impairment of single-trial memory formation by oral methylphenidate in the rat. Neurobiology of Learning and Memory 85 (2005) 125-131
18. Eckermann K., Beasley A., Yang P., Gaytan O., Swann A., and Dafny N. Methylphenidate sensitization is modulated by valproate. Life Sciences 69 (2001) 47-57
19. Ennaceur A., and Delacour J. A new one-trial test for neurobiological studies of memory in rats: I. Behavioral data. Behavioural Brain Research 31 (1988) 47-59
20. Gaytan O., al-Rahim S., Swann A., and Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sciences 61 (1997) 101-107
21. Gaytan O., Nason R., Alagugurusamy R., Swann A., and Dafny N. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate. Brain Research Bulletin 51 (2000) 485-492
22. Gaytan O., Swann A.C., and Dafny N. Disruption of sensitization to methylphenidate by a single administration of MK-801. Life Sciences 70 (2002) 2271-2285
23. Gaytan O., Yang P., Swann A., and Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Research 864 (2000) 24-39
24. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marstellar D., et al. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. Journal of Pharmacology and Experimental Therapeutics 295 (2000) 51-57
25. Goldman L.S., Genel M., Bezman R.J., and Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA: Journal of the American Medical Association 279 (1998) 1100-1107
26. Greenhill L., Kollins S., Abikoff H., McCracken J., Riddle M., Swanson J., et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 45 (2006) 1284-1293
27. Heyser C.J., Pelletier M., and Ferris J.S. The effects of methylphenidate on novel object exploration in weanling and periadolescent rats. Annals of the New York Academy of Sciences 1021 (2004) 465-469
28. Kuczenski R., and Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine. Journal of Pharmacology and Experimental Therapeutics 296 (2001) 876-883
29. Kuczenski R., and Segal D.S. Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. Journal of Neuroscience 22 (2002) 7264-7271
30. Kuczenski R., and Segal D.S. Stimulant actions in rodents: Implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biological Psychiatry 57 (2005) 1391-1396
31. Lapiz M.D.S., Fulford A., Muchimapura S., Mason R., Parker T., and Marsden C.A. Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neuroscience and Behavioral Physiology 33 (2003) 13-29
32. ®) in rats. Pharmacology, Biochemistry and Behavior 79 (2004) 641-649
33. LeBlanc-Duchin D., Taukulis H.K., Chuhan Y.S., and Batra N. Novel procedure for chronic oral administration of MPD modulates cognitive performance in the object recognition task and the object placement task in rats (2005), International Behavioral Neuroscience Society, Santa Fe, NM
34. McDougall S.A., Collins R.L., Karper P.E., Watson J.B., and Crawford C.A. Effects of repeated methylphenidate treatment in the young rat: Sensitization of both locomotor activity and stereotyped sniffing. Experimental and Clinical Psychopharmacology 7 (1999) 208-218
35. Morley K.C., Gallate J.E., Hunt G.E., Mallet P.E., and McGregor I.S. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). European Journal of Pharmacology 433 (2001) 91-99
36. Olfson M., Marcus S.C., Weissman M.M., and Jensen P.S. National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry 41 (2002) 514-521
37. Patrick K.S., Ellington K.R., and Breese G.R. Distribution of methylphenidate and p-hydroxymethylphenidate in rats. Journal of Pharmacology and Experimental Therapeutics 231 (1984) 61-65
38. Piper B.J., and Meyer J.S. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. Pharmacology, Biochemistry and Behavior 79 (2004) 723-731
39. Ramos A., and Mormède P. Stress and emotionality: A multidimensional and genetic approach. Neuroscience and Biobehavioral Reviews 22 (1998) 33-57
40. Robinson T.E., and Berridge K.C. Addiction. Annual Review of Psychology 54 (2003) 25-53
41. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 (2004) 33-46
42. Solanto M.V. Clinical psychopharmacology of AD/HD: Implications for animal models. Neuroscience and Biobehavioral Reviews 24 (2000) 27-30
43. Stanwood G.D., and Levitt P. Drug exposure early in life: Functional repercussions of changing neuropharmacology during sensitive periods of brain development. Current Opinion in Pharmacology 4 (2004) 65-71
44. Swanson J.M., and Volkow N.D. Serum and brain concentrations of methylphenidate: Implications for use and abuse. Neuroscience and Biobehavioral Reviews 27 (2003) 615-621
45. Vitiello B. Long-term effects of stimulant medications on the brain: Possible relevance to the treatment of attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 11 (2001) 25-34
46. Volkow N.D., Ding Y.-S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry 52 (1995) 456-463
47. Volkow N.D., and Insel T.R. What are the long-term effects of methylphenidate treatment?. Biological Psychiatry 54 (2003) 1307-1309
48. Wargin W., Patrick K., Kilts C., Gualtieri C.T., Ellington K., Mueller R.A., et al. Pharmacokinetics of methylphenidate in man, rat and monkey. Journal of Pharmacology and Experimental Therapeutics 226 (1983) 382-386
49. Wheeler T.L., Eppolito A.K., Smith L.N., Huff T.B., and Smith R.F. A novel method for oral stimulant administration in the neonate rat and similar species. Journal of Neuroscience Methods 159 (2006) 282-285